Lanifibranor
Lanifibranor Uses, Dosage, Side Effects, Food Interaction and all others data.
Lanifibranor is under investigation in clinical trial NCT03008070 (Phase 2b Study in NASH to Assess IVA337).
| Trade Name | Lanifibranor |
| Generic | Lanifibranor |
| Lanifibranor Other Names | Lanifibranor |
| Type | |
| Formula | C19H15ClN2O4S2 |
| Weight | Average: 434.91 Monoisotopic: 434.016177 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Lanifibranor
